Novavax (NVAX) stock forecast for 2026

The forecast has been updated: January 20, 2022 12:22


Novavax stock price online today

Analyst Target Price

270

Dividend Date

10.05.2019

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Novavax stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Novavax stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $270 target price for Novavax stock stock.

Today 200 Day Moving Average is the resistance level (188.65 $).

50 Day Moving Average is the resistance level (168.16 $).




NVAX Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 372.31 301.94 460.54 34.44 %
Feb 351.08 306.85 421.65 27.23 %
Mar 340.55 305.82 393.68 22.32 %
Apr 299.69 240.35 325.76 26.22 %
May 272.71 226.08 307.89 26.57 %
Jun 247.35 215.44 269.61 20.09 %
Jul 201.34 189.26 230.34 17.83 %
Aug 149.40 126.99 183.01 30.61 %
Sep 144.47 109.80 170.47 35.59 %
Oct 183.47 157.05 206.04 23.78 %
Nov 193.93 164.84 216.62 23.90 %
Dec 207.31 165.02 234.06 29.50 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novavax stock.


Novavax overview

Novavax Address

20 FIRSTFIELD ROAD, GAITHERSBURG, MD, US

Market Capitalization

7 442 861 000 $

EBITDA

-157 414 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-14.95

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.139

Trailing PE

-

Forward PE

3.385

EV To Revenue

9.21

EV To EBITDA

-

52 Week High

331.68

52 Week Low

91.7

50 Day Moving Average

168.16

200 Day Moving Average

188.65

Shares Outstanding

75608000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Novavax stock forecast for this year


Novavax stock forecast for Jan 2026.
Estimated Average Forecasted Novavax Price: 372.31. Negative monthly dynamics of the instrument is expected with 34.438% volatility is expected.

Pessimistic forecast: 301.94

Optimistic: 460.54


Novavax stock forecast for Feb 2026.
Estimated Average Forecasted Novavax Price: 351.08. Negative monthly dynamics of the instrument is expected with 27.227% volatility is expected.

Pessimistic forecast: 306.85

Optimistic: 421.65


Novavax stock forecast for Mar 2026.
Estimated Average Forecasted Novavax Price: 340.55. Negative monthly dynamics of the instrument is expected with 22.318% volatility is expected.

Pessimistic forecast: 305.82

Optimistic: 393.68


Novavax stock forecast for Apr 2026.
Estimated Average Forecasted Novavax Price: 299.69. Negative monthly dynamics of the instrument is expected with 26.219% volatility is expected.

Pessimistic forecast: 240.35

Optimistic: 325.76


Novavax stock forecast for May 2026.
Estimated Average Forecasted Novavax Price: 272.71. Negative monthly dynamics of the instrument is expected with 26.572% volatility is expected.

Pessimistic forecast: 226.08

Optimistic: 307.89


Novavax stock forecast for Jun 2026.
Estimated Average Forecasted Novavax Price: 247.35. Negative monthly dynamics of the instrument is expected with 20.092% volatility is expected.

Pessimistic forecast: 215.44

Optimistic: 269.61


Novavax stock forecast for Jul 2026.
Estimated Average Forecasted Novavax Price: 201.34. Negative monthly dynamics of the instrument is expected with 17.832% volatility is expected.

Pessimistic forecast: 189.26

Optimistic: 230.34


Novavax stock forecast for Aug 2026.
Estimated Average Forecasted Novavax Price: 149.40. Negative monthly dynamics of the instrument is expected with 30.612% volatility is expected.

Pessimistic forecast: 126.99

Optimistic: 183.01


Novavax stock forecast for Sep 2026.
Estimated Average Forecasted Novavax Price: 144.47. Negative monthly dynamics of the instrument is expected with 35.593% volatility is expected.

Pessimistic forecast: 109.80

Optimistic: 170.47


Novavax stock forecast for Oct 2026.
Estimated Average Forecasted Novavax Price: 183.47. Positive monthly dynamics of the instrument is expected with 23.775% volatility is expected.

Pessimistic forecast: 157.05

Optimistic: 206.04


Novavax stock forecast for Nov 2026.
Estimated Average Forecasted Novavax Price: 193.93. Positive monthly dynamics of the instrument is expected with 23.903% volatility is expected.

Pessimistic forecast: 164.84

Optimistic: 216.62


Novavax stock forecast for Dec 2026.
Estimated Average Forecasted Novavax Price: 207.31. Positive monthly dynamics of the instrument is expected with 29.495% volatility is expected.

Pessimistic forecast: 165.02

Optimistic: 234.06



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 126.05 (19.01.2022) -0.41 %
AbbVie Inc.
ABBV 135.21 (19.01.2022) -1.15 %
Aeterna Zentaris Inc.
AEZS 0.34 (18.01.2022) -5.48 %
Allakos Inc.
ALLK 7.43 (19.01.2022) 2.91 %
Allogene Therapeutics, Inc.
ALLO 11.68 (19.01.2022) -0.81 %
Amgen Inc.
AMGN 231.3 (19.01.2022) -1.08 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.22 (19.01.2022) 2.08 %
Aurora Cannabis Inc.
ACB 4.86 (19.01.2022) -4.89 %
Becton Dickinson and Company
BDX 263.87 (19.01.2022) 1.32 %
Biogen Inc.
BIIB 230.81 (19.01.2022) 0.00 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 118 (18.01.2022) -3.41 %
BioNTech SE
BNTX 161.66 (19.01.2022) -4.47 %
bluebird bio, Inc.
BLUE 7.55 (19.01.2022) -4.55 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 64.72 (19.01.2022) -0.26 %
Canopy Growth Corp.
CGC 7.64 (19.01.2022) -1.80 %
Castle Biosciences, Inc.
CSTL 33.17 (19.01.2022) -1.46 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 245.05 (19.01.2022) -0.82 %
Emergent BioSolutions Inc.
EBS 52.22 (14.01.2022) 5.54 %
Exelixis, Inc.
EXEL 17.08 (19.01.2022) -1.73 %
G1 Therapeutics, Inc.
GTHX 9.07 (19.01.2022) -0.44 %
Gilead Sciences, Inc.
GILD 70.43 (18.01.2022) -1.87 %
GlaxoSmithKline plc
GSK 46.82 (18.01.2022) 2.97 %
GoodRx Holdings, Inc.
GDRX 25.9 (18.01.2022) -3.54 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.01 (18.01.2022) 0.17 %
Inovio Pharmaceuticals, Inc.
INO 4.19 (19.01.2022) -1.99 %
Johnson & Johnson
JNJ 166.58 (19.01.2022) -0.31 %
Medtronic plc.
MDT 107.76 (19.01.2022) 0.25 %
Merck & Co., Inc.
MRK 81.29 (19.01.2022) -0.31 %
Moderna, Inc.
MRNA 186.61 (18.01.2022) -8.85 %
Novartis AG
NVS 89.54 (18.01.2022) -1.12 %
Novavax, Inc.
NVAX 92.33 (19.01.2022) -6.21 %
ObsEva SA
OBSV 1.76 (18.01.2022) -8.33 %
OrganiGram Holdings Inc.
OGI 1.54 (19.01.2022) -0.65 %
Pfizer Inc.
PFE 53.54 (19.01.2022) -1.05 %
Regeneron Pharmaceuticals, Inc.
REGN 618.11 (19.01.2022) 1.13 %
Sanofi
SNY 52.08 (19.01.2022) -0.17 %
Schrodinger, Inc.
SDGR 27.85 (19.01.2022) -3.27 %
Senseonics Holdings, Inc.
SENS 2.77 (18.01.2022) -2.46 %
Sorrento Therapeutics, Inc.
SRNE 4.23 (18.01.2022) -7.24 %
Stryker Corp.
SYK 260.48 (18.01.2022) -2.34 %
Sundial Growers Inc.
SNDL 0.5465 (18.01.2022) -3.10 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.84 (19.01.2022) -0.56 %
Thermo Fisher Scientific Inc.
TMO 590.1 (18.01.2022) -0.79 %
Tilray, Inc.
TLRY 6.29 (18.01.2022) -8.31 %
UnitedHealth Group, Inc.
UNH 468.69 (14.01.2022) 0.27 %
Veeva Systems Inc.
VEEV 218.27 (18.01.2022) -2.49 %
Zomedica Corp.
ZOM 0.336 (19.01.2022) -4.00 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.45 (18.01.2022) -6.84 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.